home
Author : adminDate : 2023-10-13 18:52

Elevar Therapeutics Highlights Competitiveness of Rivoceranib at Global Healthcare Conference 2023

SEOUL, South Korea, October 12, 2023 (IT Times) - Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd announced today that it participated in a fireside chat as an invited speaker at Cantor Fitzgerald Global Healthcare Conference 2023 taking place in New York, NY, September 26-28, 2023.

Please refer to the following website for further details : https://www.ittimes.com/news/articleView.html?idxno=8189